Company intelligence / Profile preview

XynManagement

United States

Ownership: Private
Development stage: Other

Overview

XynQAPI and Waitlist Management tools were adopted by numerous transplant centers to simplify transplant quality management, SRTR reporting, and active engagement of patients on transplant waitlists; centers using XynQAPI saw up to 15% improvement in 1-year graft and patient survival within one year of adoption

Therapeutic areas: NephrologyCardiovascularHematologyPulmonology
Industry: Digital Health Medical Devices

Partnerships

Integrated into CareDx's Digital Solutionscollaborates with EMR/EHR vendors via data integration (e.g., UNet, major EMR systems)

Beyond the preview

Go deeper on XynManagement.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XynManagement.

Explore the full profile